Interventional Oncology Market 2019- 2025
Interventional Oncology Market is expected to grow at a
CAGR of 7.7% from 2019 to reach $1,506.3 million by
2025 | Meticulous Research
Meticulous Research®– leading global market research company published a research
report titled Interventional oncology Market by Procedure [Embolization (TARE,
TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product
[Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and
End User– Global Forecast to 2025. According to this latest publication from
Meticulous Research®, the global interventional oncology market is expected to grow
at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025. The high growth of
interventional oncology market is mainly attributed to growing preference for
minimally invasive treatment procedures, increasing incidence of cancer, rising number
of hospitals, and technological advancements in the field of radiology. However, high
cost and risks associated with the interventional oncology procedures and paucity of
skilled healthcare professionals are the key factors expected to hinder the adoption of
interventional oncology procedures.
Get Free Sample Copy of This Report at:
https://www.meticulousresearch.com/request-samplereport/cp_id=4951
Future looks bright for interventional oncology
The global interventional oncology market study presents historical market data in
terms of values (2017 and 2018), estimated current data (2019), and forecasts for
2025-by procedure (embolization [TARE, TACE], ablation thermal ablation
[microwave, RF ablation]), by product (embolization [SIR-spheres, theraspheres],
ablation), application (liver, lung, breast), end user (hospitals, ambulatory care center),
and geography. The study also evaluates industry competitors and analyzes the market
at regional and country level.
On the basis of procedure, the embolization procedure segment accounted for the
largest share of this market in 2018. The large share of this segment is mainly
attributed to better clinical outcomes, high specificity towards tumor cells, and
continuous advancements in embolization procedures and associated agents. In
embolization segment, trans arterial radioembolization accounted for the largest share
and is projected to grow at the highest CAGR during the forecast period. The high
growth of this segment can be attributed to successful clinical outcomes and high
efficiency due to localized radiation treatment & use of radioactive isotopes such as
yttrium Y-90 in the procedure.
Follow Us On:
Interventional Oncology Market 2019- 2025
Browse in-depth Report with TOC at:
https://www.meticulousresearch.com/product/InterventionalOncology-Market-4951/
The interventional oncology procedures, on the basis of products are majorly classified
into tumor embolization (radioactive embolic agents/radioembolic agents and nonradioactive embolic agents) and tumor ablation (generators and consumables &
accessories). Due to localized & directed radiation and favorable reimbursement
scenario for radioembolization procedures, radioactive embolic agents segment
commanded the largest share of the global interventional oncology market in 2018. The
key factors driving the growth of this market include the increasing accessibility to the
embolization products, rising coverage of the product for reimbursement across the
globe, and increasing incidence of cancer & related mortality.
On the basis of application, liver cancer accounted for the largest share of the global
interventional oncology market in 2018. The major share of this segment is primarily
attributed to the availability of wide range of embolization and ablation products
globally for liver cancer treatment and growing prevalence of the disease and related
mortality. Furthermore, this segment is also estimated to grow at the highest CAGR
during the forecast period with rising diagnosis and treatment rate of the disease with
growing awareness about the fatality and benefits of early diagnosis and treatment
across the globe, and growing access to innovative products and their increasing
coverage for reimbursement.
The hospitals segment accounted for the largest share in 2018. This is primarily
attributed to large volume of interventional oncology procedures performed in
hospitals. On the other hand, ambulatory care centers are expected to grow at the
highest CAGR in the forecast period due to provision of cost-effective treatment
procedures.
Top 10 Companies in Interventional Oncology Market at:
https://meticulousblog.org/top-10-companies-in-interventionaloncology-market/
This research report analyzes major geographies and provides comprehensive analysis
for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and
Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and
Middle East & Africa. North America commanded the largest share of the global
interventional oncology market in 2018, followed by Europe and Asia Pacific.
However, Asia Pacific region is expected to grow at the highest CAGR during the
forecast period. Growth in this market is expected to be driven by large pool of cancer
patients; growing government focus on healthcare sector; increasing health insurance
Follow Us On:
Interventional Oncology Market 2019- 2025
penetration; and increasing disposable income of the population that improved the
access to diagnosis and treatment. In addition, favorable government policies and
healthcare structural reforms are further expected to drive the market growth.
The key players operating in the global interventional oncology market are Boston
Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit
Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc,
Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc.,
Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies
Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.
Key questions answered in the report:
• Which are the high growth market segments in terms of products, procedures,
applications, end users, and region/countries?
• What was the historical market for interventional oncology across the globe?
• What are the market forecasts and estimates for the period 2019-2025?
• What are the major drivers, restraints, opportunities, and trends in the global
interventional oncology market?
• Who are the major players in the global interventional oncology market?
• How is the competitive landscape and who are the market leaders in the
global interventional oncology market?
• What are the recent developments in the global interventional oncology
market?
• What are the different strategies adopted by the major players in the global
interventional oncology market?
• What are the geographical trends and high growth regions/ countries?
Table of Contents:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
Continued…
Follow Us On:
Interventional Oncology Market 2019- 2025
About Us:
The name of our company defines our services, strengths, and values. Since the inception,
we have endeavoured to research, analyze and present the critical market data with great
attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market
Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956.
Since its incorporation, with the help of its unique research methodologies, the company
has become the leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong
capabilities in data collection, interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design our meticulously analyzed
intelligent and value-driven syndicate market research reports, custom studies, quick
turnaround research, and consulting solutions to address business challenges of sustainable
growth.
Contact Us:
Khushal
Meticulous Research®
Contact Sales- +1-646-781-8004
Email: [email protected]
Website: https://www.meticulousresearch.com
Browse Our Blog: https://globalmarketstudy.blogspot.com/
Find us on: | LinkedIn | Twitter |
Follow Us On: